# Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris

> **NCT00263718** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 360 (—)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Calcipotriol plus betamethasone dipropionate (LEO 80185) gel

## Key facts

- **NCT ID:** NCT00263718
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 360 (—)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263718, "Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00263718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*